Management of COPD.
- Author:
Ki Suck JUNG
1
Author Information
- Publication Type:Review
- Keywords: COPD; Treatment; Pharmacologic therapy; Non-pharmacologic therapy
- MeSH: Aged; Bronchodilator Agents; Humans; Korea; Oxygen; Prevalence; Pulmonary Disease, Chronic Obstructive; Quality of Life; Smoking Cessation; Theophylline; Vaccination
- From:Korean Journal of Medicine 2009;77(4):422-428
- CountryRepublic of Korea
- Language:Korean
- Abstract: The prevalence of chronic obstructive pulmonary disease (COPD) in Korea is reported to be 17.5% in aged over 45 years. The overall approach should be individualized and dependent upon the severity of the disease and clinical status of the patient. Objectives of COPD treatment are improvement of airflow obstruction, prevention and management of co-morbidity and complication of COPD and upgrading in the quality of life. Pharmacologic therapy includes bronchodilators such as beta-2 agonists, anticholinergic and theophylline. Another key pharmacologic agent is glucocorticosteroid which reduces acute exaceerbation and inflammatory burden in COPD airways. Non-pharmacologic management is not less important. Education including smoking cessation, rehabilitation, home oxygen therapy along with appropriate vaccination. More importantly, doctor-patient-patron relationship plays a central role in long-term management of COPD.
